المؤلفون: Joosse, ME, Aardoom, MA, Kemos, P, Turner, D, Wilson, DC, Koletzko, S, Martin-De-Carpi, J, Fagerberg, UL, Spray, C, Tzivinikos, C, Sladek, M, Shaoul, R, Roma-Giannikou, E, Bronsky, J, Serban, DE, Ruemmele, FM, Garnier-Lengline, H, Veres, G, Hojsak, I, Kolho, KL, Davies, IH, Aloi, M, Lionetti, P, Hussey, S, Veereman, G, Braegger, CP, Trindade, E, Wewer, AV, Hauer, AC, Vries, ACH, Boneh, RS, Shabat, CS, Levine, A, Ridder, L

المصدر: Alimentary pharmacology & therapeutics. 48(5):523-537

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:138943525

المؤلفون: van Leeuwen Fe, van Dijk M, Dalit Modan-Moses, Dorine Bresters, Claudia Spix, C.B. Lambalk, Jacqueline J. Loonen, Eva Clemens, A. Overbeek, Wassim Chemaitilly, van den Berg Mh, Gertjan L. Kaspers, Beerendonk Ccm, L. L. Robison, Sophie D. Fosså, van der Heiden-van der Loo M, Desiree Grabow, Peter Kaatsch, A.G. Uitterlinden, Melissa M. Hudson, van den Heuvel-Eibrink M, Russell J. Brooke, L. C. M. Kremer, van der Pal Hj, W.J.E. (Wim) Tissing, Falck Winther J, van der Kooi Alf, J. Kruseova, Uta Dirksen, Laven Jse, Claire Berger, Tomáš Kepák, Ronckers Cr, James M. Byrne, Pluijm Smf, Melanie Kaiser, de Vries Ach, Mvan Dulmen-den Broeder E, Linda Broer, Yutaka Yasui, Jesse H. Krijthe, Birgitta Versluys, O. Zolk, Riccardo Haupt

المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Pediatrics, Obstetrics and gynaecology, Amsterdam Reproduction & Development (AR&D), CCA - Cancer Treatment and quality of life, CCA - Cancer biology and immunology, Obstetrics & Gynecology, Internal Medicine

المصدر: Human Reproduction, 36(4), 1120-1133. Oxford University Press
van der Kooi, A L L F, van Dijk, M, Broer, L, van den Berg, M H, Laven, J S E, van Leeuwen, F E, Lambalk, C B, Overbeek, A, Loonen, J J, van der Pal, H J, Tissing, W J, Versluys, B, Bresters, D, Beerendonk, C C M, Ronckers, C R, van der Heiden-van der Loo, M, Kaspers, G L, de Vries, A C H, Robison, L L, Hudson, M M, Chemaitilly, W, Byrne, J, Berger, C, Clemens, E, Dirksen, U, Falck Winther, J, Fosså, S D, Grabow, D, Haupt, R, Kaiser, M, Kepak, T, Kruseova, J, Modan-Moses, D, Pluijm, S M F, Spix, C, Zolk, O, Kaatsch, P, Krijthe, J H, Kremer, L C, Yasui, Y, Brooke, R J, Uitterlinden, A G, van den Heuvel-Eibrink, M M & van Dulmen-den Broeder, E 2021, ' Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function ', Human Reproduction, vol. 36, no. 4, pp. 1120-1133 . https://doi.org/10.1093/humrep/deaa342
Human Reproduction (Oxford, England)
Human Reproduction, 36, 4, pp. 1120-1133
Human Reproduction, 36, 1120-1133
van der Kooi, A-L L F, van Dijk, M, Broer, L, van den Berg, M H, Laven, J S E, van Leeuwen, F E, Lambalk, C B, Overbeek, A, Loonen, J J, van der Pal, H J, Tissing, W J, Versluys, B, Bresters, D, Beerendonk, C C M, Ronckers, C C R, van der Heiden-van der Loo, M, Kaspers, G L, de Vries, A C H, Robison, L L, Hudson, M M, Chemaitilly, W, Byrne, J, Berger, C, Clemens, E, Dirksen, U, Falck Winther, J, Fosså, S D, Grabow, D, Haupt, R, Kaiser, M, Kepak, T, Kruseova, J, Modan-Moses, D, Pluijm, S M F, Spix, C, Zolk, O, Kaatsch, P, Krijthe, J H, Kremer, L C, Yasui, Y, Brooke, R J, Uitterlinden, A G, van den Heuvel-Eibrink, M M & van Dulmen-den Broeder, E 2021, ' Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function ', Human Reproduction, vol. 36, no. 4, pp. 1120-1133 . https://doi.org/10.1093/humrep/deaa342

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_treatment, Medizin, PANCARELIFE, Cohort Studies, ovarian reserve, 0302 clinical medicine, Fertility preservation, Child, media_common, fertility, biology, Rehabilitation, Intracellular Signaling Peptides and Proteins, Obstetrics and Gynecology, WOMEN, Anti-Müllerian hormone, Women's cancers Radboud Institute for Health Sciences [Radboudumc 17], 3. Good health, RESERVE, PREGNANCY, 030220 oncology & carcinogenesis, Cohort, Female, Cohort study, Adult, medicine.medical_specialty, MENOPAUSE, Anti-Mullerian Hormone/genetics, Adolescent, LONG-TERM, ANTI-MULLERIAN HORMONE, gonadotoxicity, Protein Serine-Threonine Kinases, Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18], 03 medical and health sciences, Ovarian function, All institutes and research themes of the Radboud University Medical Center, AGE, SDG 3 - Good Health and Well-being, FEMALE SURVIVORS, Internal medicine, Genetic model, medicine, media_common.cataloged_instance, Humans, childhood cancer, CHILDHOOD-CANCER SURVIVORS, European union, Ovarian reserve, Retrospective Studies, Chemotherapy, business.industry, Data Science, Ovary, Retrospective cohort study, Original Articles, Reproductive Genetics, AcademicSubjects/MED00905, 030104 developmental biology, Reproductive Medicine, biology.protein, business, survivorship

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ae7c525b5d2c7161af711da3873f478
https://research.rug.nl/en/publications/063b1e16-52a7-45b0-b625-23f28047a5d1

المؤلفون: Maarten H Lequin, de Vries Ach, Riksta Dikkers

المصدر: Journal of Pulmonary & Respiratory Medicine. 6

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Posaconazole, medicine.diagnostic_test, business.industry, medicine.medical_treatment, 030106 microbiology, Physical examination, medicine.disease, Surgery, 03 medical and health sciences, medicine.anatomical_structure, Occlusion, medicine, Heart murmur, Thoracotomy, medicine.symptom, Thrombus, business, Artery, Computed tomography angiography, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::a7b924f90488d1a28f53cd406e025fd9
https://doi.org/10.4172/2161-105x.1000351

المؤلفون: Onvlee-Dekker IM, De Vries ACH, Ten Harkel ADJ

المصدر: Archives of Disease in Childhood; Mar2007, Vol. 92 Issue 3, p244-245, 2p

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Veenbergen S; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Jugooa R; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Te Marvelde J; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., de Vries ACH; Department of Pediatrics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., van der Velden VHJ; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

المصدر: Leukemia & lymphoma [Leuk Lymphoma] 2024 Aug; Vol. 65 (8), pp. 1186-1189. Date of Electronic Publication: 2024 Apr 08.

نوع المنشور: Letter; Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

مواضيع طبية MeSH: Bone Marrow*/pathology, Humans ; Child ; Child, Preschool ; Adolescent ; Bone Marrow Cells/pathology ; Infant ; Male ; Female

المؤلفون: Maas A; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. a.maas-9@prinsesmaximacentrum.nl., Maurice-Stam H; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Feijen LEAM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Teepen JC; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van der Aa-van Delden AM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Streefkerk N; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van Dulmen-den Broeder E; Amsterdam UMC/Location VUmc, Amsterdam, The Netherlands., Tissing WJE; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Beatrix Children's Hospital, University of Groningen/University Medical Center Groningen, Groningen, The Netherlands., Loonen JJ; Radboud University Medical Center, Nijmegen, The Netherlands., van der Pal HJH; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., de Vries ACH; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Sophia Children's Hospital, Erasmus Medical Center, Rotterdam, The Netherlands., van den Heuvel-Eibrink MM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Sophia Children's Hospital, Erasmus Medical Center, Rotterdam, The Netherlands.; University Medical Center Utrecht, Wilhelmina Children's Hospital, Utrecht, the Netherlands., Ronckers C; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Division of Childhood Cancer Epidemiology, Institute of Medical Biostatistics Informatics and Epidemiology, University Medical Center of the Johannes Gutenberg University, Mainz, Germany., Neggers S; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Medicine, Section Endocrinology, Erasmus Medical Center, Rotterdam, The Netherlands., Bresters D; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Willem Alexander Children's Hospital/ Leiden University Medical Center, Leiden, The Netherlands., Louwerens M; Leiden University Medical Center, Leiden, The Netherlands., Versluys BAB; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Wilhelmina Children's Hospital/University Medical Center Utrecht, Utrecht, The Netherlands., van der Heiden-van der Loo M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Kremer LCM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; University Medical Center Utrecht, Wilhelmina Children's Hospital, Utrecht, the Netherlands.; Department of Pediatrics, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Grootenhuis M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.

مؤلفون مشاركون: Dutch LATER study group

المصدر: Journal of cancer survivorship : research and practice [J Cancer Surviv] 2024 Jun 22. Date of Electronic Publication: 2024 Jun 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Science + Business Media Country of Publication: United States NLM ID: 101307557 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1932-2267 (Electronic) Linking ISSN: 19322259 NLM ISO Abbreviation: J Cancer Surviv Subsets: MEDLINE

المؤلفون: Penson A; Center of Expertise for Cancer Survivorship, Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Walraven I; Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands., Bronkhorst E; Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands., Grootenhuis MA; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Maurice-Stam H; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Loo MVH; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Tissing WJE; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Oncology/Hematology, Beatrix Children's Hospital/University of Groningen/University Medical Center Groningen, Groningen, The Netherlands., van der Pal HJH; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., de Vries ACH; Department of Pediatric Oncology, Erasmus Medical Center, Rotterdam, The Netherlands., Bresters D; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Ronckers CM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Division of Childhood Cancer Epidemiology, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University, Mainz, Germany., van den Heuvel-Eibrink MM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Oncology, Erasmus Medical Center, Rotterdam, The Netherlands., Neggers S; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Medicine, section Endocrinology, Erasmus Medical Center, Rotterdam, The Netherlands., Versluys BAB; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Louwerens M; Department of Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands., Pluijm SMF; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Blijlevens N; Center of Expertise for Cancer Survivorship, Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., van Dulmen-den Broeder E; Department of Pediatric Oncology/Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands., Kremer LCM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department Pediatric Oncology, Emma Children's Hospital, University of Amsterdam, Amsterdam, The Netherlands., Knoop H; Department of Medical Psychology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands., Loonen J; Center of Expertise for Cancer Survivorship, Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.

مؤلفون مشاركون: Dutch LATER study group

المصدر: Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Jun; Vol. 71 (6), pp. e30951. Date of Electronic Publication: 2024 Mar 31.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-5017 (Electronic) Linking ISSN: 15455009 NLM ISO Abbreviation: Pediatr Blood Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Cancer Survivors*/psychology , Neoplasms*/complications , Neoplasms*/psychology, Humans ; Male ; Female ; Child ; Adolescent ; Fatigue/etiology ; Adult ; Fatigue Syndrome, Chronic/psychology ; Fatigue Syndrome, Chronic/etiology ; Quality of Life ; Follow-Up Studies ; Young Adult ; Child, Preschool

المؤلفون: van der Perk MEM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. Electronic address: m.e.m.vanderperk@prinsesmaximacentrum.nl., Broer L; Department of Internal Medicine, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands., Yasui Y; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee., Laven JSE; Department of Obstetrics and Gynecology, Erasmus MC University Medical Center, Rotterdam, the Netherlands., Robison LL; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee., Tissing WJE; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of pediatric oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Versluys B; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Bresters D; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Kaspers GJL; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Lambalk CB; Department of Obstetrics and Gynaecology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Overbeek A; Department of Obstetrics and Gynaecology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Loonen JJ; Department of Haematology, Radboud University Medical Center, Nijmegen, the Netherlands., Beerendonk CCM; Department of Obstetrics and Gynaecology, Radboud University Medical Center, Nijmegen, the Netherlands., Byrne J; Boyne Research Institute, Bettystown, Ireland., Berger C; Department of Paediatric Oncology, University Hospital, Saint-Etienne, France; Lyon University, Jean Monnet University, INSERM, Sainbiose, Saint-Etienne, France., Clemens E; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van Dulmen-den Broeder E; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Dirksen U; Pediatrics III, West German Cancer Centre, University Hospital Essen, Essen, Germany; German Cancer Research Centre, DKTK, Sites Duesseldorf-Essen, Essen, Germany., van der Pal HJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., de Vries ACH; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Winther JF; Danish Cancer Society Research Center, Childhood Cancer Research Group, Copenhagen, Denmark; Department of Clinical Medicine, Faculty of Health, Aarhus University and University Hospital, Aarhus, Denmark., Ranft A; Pediatrics III, West German Cancer Centre, University Hospital Essen, Essen, Germany; German Cancer Research Centre, DKTK, Sites Duesseldorf-Essen, Essen, Germany., Fosså SD; Department of Oncology, Oslo University Hospital, Oslo, Norway., Grabow D; Division of Childhood Cancer Epidemiology, German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Muraca M; Division of Pediatric Hematology and Oncology, DOPO Clinic, IRCCS Istituto Giannina Gaslini, Via G. Gaslini, Genoa, Italy., Kaiser M; Division of Childhood Cancer Epidemiology, German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Kepák T; University Hospital Brno, International Clinical Research Center (FNUSA-ICRC), Masaryk University, Brno, Czech Republic., Kruseova J; Department of Pediatric Hematology and Oncology, Motol University Hospital, Prague, Czech Republic., Modan-Moses D; The Edmond and Lily Safra Children's Hospital, Chaim Sheba Medical Center, Tel Hashomer, Israel; The Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel., Spix C; Division of Childhood Cancer Epidemiology, German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Zolk O; Institute of Clinical Pharmacology, Brandenburg Medical School Theodor Fontane, Immanuel Klinik Rüdersdorf, Neuruppin, Germany., Kaatsch P; Division of Childhood Cancer Epidemiology, German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Kremer LCM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Brooke RJ; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee., Wang F; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee., Baedke JL; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee., Uitterlinden AG; Department of Internal Medicine, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands., Bos AME; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Reproductive Medicine, University Medical Center, Utrecht, the Netherlands., van Leeuwen FE; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Ness KK; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee., Hudson MM; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee; Division of Survivorship, Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee., van der Kooi ALF; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Obstetrics and Gynecology, Erasmus MC University Medical Center, Rotterdam, the Netherlands., van den Heuvel-Eibrink MM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Division of Child Health, Wilhelmina Children's Hospital, University Medical Center Utrecht, the Netherlands.

مؤلفون مشاركون: PanCareLIFE consortium

المصدر: Fertility and sterility [Fertil Steril] 2024 May 09. Date of Electronic Publication: 2024 May 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier for the American Society for Reproductive Medicine Country of Publication: United States NLM ID: 0372772 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-5653 (Electronic) Linking ISSN: 00150282 NLM ISO Abbreviation: Fertil Steril Subsets: MEDLINE

المؤلفون: Leerink JM; Amsterdam UMC, University of Amsterdam, Heart Center, Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Feijen EAM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., de Baat EC; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Merkx R; Radboud University Medical Center, Department of Medical Imaging, Nijmegen, the Netherlands., van der Pal HJH; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Tissing WJE; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Beatrix Children's Hospital, Department of Pediatric Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Louwerens M; Department of Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands., van den Heuvel-Eibrink MM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Department of Pediatric Oncology, Erasmus Medical Center, Rotterdam, the Netherlands.; University Medical Center Utrecht, Wilhelmina Children's Hospital, Utrecht, the Netherlands., Versluys AB; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van Dalen EC; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van der Heiden-van der Loo M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Bresters D; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Willem Alexander Children's Hospital/Leiden University Medical Center, Leiden, the Netherlands., Ronckers CM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Carl von Ossietzky University of Oldenburg, Oldenburg, Germany., de Vries ACH; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Department of Pediatric Oncology, Erasmus Medical Center, Rotterdam, the Netherlands., Neggers S; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Department of Medicine, Section Endocrinology, Erasmus Medical Center, Rotterdam, the Netherlands., Kapusta L; Radboud University Medical Center, Department of Pediatric Cardiology, Amalia Children's Hospital, Nijmegen, the Netherlands.; Pediatrics, Pediatric Cardiology Unit, Tel Aviv Sourasky Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel., Loonen J; Department of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands., Pinto YM; Amsterdam UMC, University of Amsterdam, Heart Center, Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands., Kremer LCM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; University Medical Center Utrecht, Wilhelmina Children's Hospital, Utrecht, the Netherlands.; Amsterdam UMC, University of Amsterdam, Emma Children's Hospital, Amsterdam, the Netherlands., Mavinkurve-Groothuis AMC; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Kok WEM; Amsterdam UMC, University of Amsterdam, Heart Center, Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands.

المصدر: JACC. CardioOncology [JACC CardioOncol] 2024 Apr 16; Vol. 6 (2), pp. 236-247. Date of Electronic Publication: 2024 Apr 16 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101761697 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-0873 (Electronic) Linking ISSN: 26660873 NLM ISO Abbreviation: JACC CardioOncol Subsets: PubMed not MEDLINE